Q:
A:
Serbian pharmaceutical products may appear on Mexican market
Belgrade,
17 November 2009
Minister of Health Tomica Milosavljevic today said that the Mexican Health Minister’s visit to Serbia can be very beneficial to the Serbian pharmaceutical industry.
Milosavljevic told a press conference that yesterday he visited the Torlak Virology and Immunology Institute and the Galenika pharmaceutical company with Mexican Minister of Health Jose Angel Cordova, adding that this creates possibilities for Serbia to place its pharmaceutical products on the Mexican market.
He stressed that any concrete effects from the Mexican delegation’s visit are yet to be seen, voicing his belief that citizens in both countries will benefit from it.
Milosavljevic said that he and Cordova exchanged experiences about the outbreak of the type A (H1N1) flu pandemic, bearing in mind that Mexico was particularly stricken by this disease.
No one could have predicted the outbreak of the epidemic and Mexico’s experience is very important, the Minister said, adding that both countries are implementing similar measures for fighting the H1N1 virus.
He noted that a certain number of citizens in Mexico did not trust the vaccine, just as is the case in Serbia, but health and educational workers insisted on it in order to prevent mass infection.
Milosavljevic stressed that Serbia is on the brink of a European pandemic crisis, therefore it is important that as many citizens as possible are inoculated against the new flu.
In two to three weeks the largest inoculation in Serbia will begin, it will be organised in several places at once over a very short period, the Minister announced, stressing that the decision on receiving the vaccination will be made by each person individually.
The more people who are inoculated, the less risk of the virus spreading, the Minister said, stressing that the progress of the epidemiological situation cannot be predicted with much accuracy.
Milosavljevic said that the country is faced with the greatest number of respiratory infections in the last 10–15 years, specifying that around 20,000 people are currently affected.
Minister Cordova said that next week all health workers in Mexico will be inoculated and by the end of the year 30% of the population will have received the vaccine, that is, pregnant women and persons with high health risks.
My visit to Galenika will enable Mexico to procure medicines and other products from this company. I was also convinced of the high quality standards of the announced production of H1N1 vaccine in Torlak, the Mexican Minister said.
He also said he noticed many similarities between the Serbian and Mexican health systems, adding that the globalisation process forces the two countries to cooperate in health protection.
He stressed that any concrete effects from the Mexican delegation’s visit are yet to be seen, voicing his belief that citizens in both countries will benefit from it.
Milosavljevic said that he and Cordova exchanged experiences about the outbreak of the type A (H1N1) flu pandemic, bearing in mind that Mexico was particularly stricken by this disease.
No one could have predicted the outbreak of the epidemic and Mexico’s experience is very important, the Minister said, adding that both countries are implementing similar measures for fighting the H1N1 virus.
He noted that a certain number of citizens in Mexico did not trust the vaccine, just as is the case in Serbia, but health and educational workers insisted on it in order to prevent mass infection.
Milosavljevic stressed that Serbia is on the brink of a European pandemic crisis, therefore it is important that as many citizens as possible are inoculated against the new flu.
In two to three weeks the largest inoculation in Serbia will begin, it will be organised in several places at once over a very short period, the Minister announced, stressing that the decision on receiving the vaccination will be made by each person individually.
The more people who are inoculated, the less risk of the virus spreading, the Minister said, stressing that the progress of the epidemiological situation cannot be predicted with much accuracy.
Milosavljevic said that the country is faced with the greatest number of respiratory infections in the last 10–15 years, specifying that around 20,000 people are currently affected.
Minister Cordova said that next week all health workers in Mexico will be inoculated and by the end of the year 30% of the population will have received the vaccine, that is, pregnant women and persons with high health risks.
My visit to Galenika will enable Mexico to procure medicines and other products from this company. I was also convinced of the high quality standards of the announced production of H1N1 vaccine in Torlak, the Mexican Minister said.
He also said he noticed many similarities between the Serbian and Mexican health systems, adding that the globalisation process forces the two countries to cooperate in health protection.
-
Belgrade, 22 January 2025Egypt one of Serbia’s closest partners on international stage
-
Belgrade, 9 July 2024Support for 104 associations in diaspora that preserve Serbian language, culture
-
Belgrade, 15 April 2024Competition for StarTech grants open until 31 May
-
Belgrade, 2 October 2023Serbia respects Resolution 1244 and will do everything to preserve peace
-
Belgrade, 13 September 2023Day of Serbian Unity to be celebrated outside borders of Serbia, Republika Srpska for the first time
-
Belgrade, 8 August 2023RSD 24.2m in state aid paid out to citizens affected by storm
-
Belgrade, 17 June 2023Belgrade is doing everything to preserve peace in Kosovo and Metohija
-
Belgrade, 15 June 2023Slovenia will continue to support Serbia on its way to EU
-
Belgrade, 5 May 2023Emergency measures, tightening of conditions for possessing weapons
-
Belgrade, 3 May 2023Three days of mourning in Serbia over tragedy at Vladislav Ribnikar primary school